IMMUTEP LIMITED - AMER

Immutep To Present At The Jefferies Virtual Healthcare Conference

25 May 2021 08:00:04 By Nasdaq GlobeNewswire

Immutep Announces Publication of TACTI-002 and INSIGHT-004 Abstracts for ASCO 2021 Annual Meeting

20 May 2021 08:00:02 By Nasdaq GlobeNewswire

Immutep Operational Update

07 May 2021 08:00:00 By Nasdaq GlobeNewswire

Immutep To Announce New TACTI-002 and INSIGHT-004 Data in Poster Presentations and Discussion at the ASCO 2021 Annual Meeting

28 Apr 2021 10:21:40 By Nasdaq GlobeNewswire

Immutep Quarterly Activities Report

19 Apr 2021 08:00:01 By Nasdaq GlobeNewswire

Immutep Receives A$1,155,055 R&D Tax Incentive

16 Apr 2021 08:00:00 By Nasdaq GlobeNewswire

Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer

08 Apr 2021 08:00:01 By Nasdaq GlobeNewswire

Immutep Announces European Patent Grant For LAG525 Antibody In Combination Therapy

07 Apr 2021 08:00:02 By Nasdaq GlobeNewswire

Immutep To Participate In A Fireside Chat At The Inaugural M Vest And Maxim Group Emerging Growth Virtual Conference

17 Mar 2021 08:00:00 By Nasdaq GlobeNewswire

Immutep Enters Second Collaboration With MSD For A New Randomised Phase IIB Trial In Head And Neck Cancer

16 Mar 2021 08:00:01 By Nasdaq GlobeNewswire